Filing Details
- Accession Number:
- 0001225208-15-007187
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-06 19:19:47
- Reporting Period:
- 2015-03-05
- Filing Date:
- 2015-03-06
- Accepted Time:
- 2015-03-06 19:19:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
78003 | Pfizer Inc | PFE | Pharmaceutical Preparations (2834) | 135315170 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1372915 | C Ian Read | Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-03-05 | 100 | $34.81 | 1,475,857 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 200 | $34.66 | 1,475,657 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 200 | $34.65 | 1,475,457 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 200 | $34.63 | 1,475,257 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 300 | $34.62 | 1,474,957 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 400 | $34.68 | 1,474,557 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 420 | $34.61 | 1,474,137 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 500 | $34.78 | 1,473,637 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 500 | $34.67 | 1,473,137 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 600 | $34.64 | 1,472,537 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 700 | $34.79 | 1,471,837 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 700 | $34.71 | 1,471,137 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 700 | $34.70 | 1,470,437 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 700 | $34.60 | 1,469,737 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 800 | $34.69 | 1,468,937 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 900 | $34.72 | 1,468,037 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 1,400 | $34.77 | 1,466,637 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 1,600 | $34.76 | 1,465,037 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 1,800 | $34.73 | 1,463,237 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 3,000 | $34.74 | 1,460,237 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 3,600 | $34.75 | 1,456,637 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 4,827 | $34.59 | 1,451,810 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 18,021 | $34.57 | 1,433,789 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-05 | 25,332 | $34.58 | 1,408,457 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 9,942 | Indirect | By Rule 16b-3 Plan |
Common Stock | 33,809 | Indirect | By Trust |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014.